AI in healthcare: hype or real benefit?

AI can improve diagnostics, drug development, and healthcare logistics. But the big challenge lies not in the algorithms, but in the data, regulations, culture, and trust. For AI to truly deliver value in healthcare, we need to move beyond the hype and build a robust infrastructure for implementation.

Artificial intelligence has quickly become one of the most talked-about tech areas in healthcare and life sciences. Almost every day, we see headlines like "AI beats doctors at detecting cancer," "AI cuts drug development time in half," or "AI solves diagnostic bottlenecks."

But behind the headlines lies a more complex reality. While technology offers enormous potential for improving patient safety, efficiency, and innovation, major questions remain: Are we ready to use AI in healthcare in earnest? Do we have the infrastructure and regulations needed to ensure reliability and trust? And perhaps most importantly, what is hype, and what is real benefit here and now?

Why AI is now making a serious impact on healthcare

AI has existed in various forms for decades, but only now is the technology mature enough to seriously transform healthcare. Three factors are behind this breakthrough. First, the amount of available data has increased exponentially. Electronic patient records, diagnostic imaging, genetic data, and sensors now generate more information than any human can comprehend.

Secondly, computing power has increased significantly, with powerful GPUs and cloud-based solutions making it possible to train advanced models in a short time. Thirdly, algorithms have improved significantly, especially in deep learning, where AI models have become dramatically better at identifying patterns in complex datasets. Together, these advances have paved the way for a wide range of AI applications in healthcare, from more accurate diagnoses to more efficient logistics.

Three key areas of application where AI is already creating value

1. Diagnostics and image analysis

AI systems can analyze X-rays, MRIs, CT scans, and pathology slides with impressive precision. Studies show that AI can identify early stages of diseases such as lung cancer, breast cancer, and eye diseases, sometimes as well as or better than experienced radiologists.

The key here is not to replace doctors, but to act as a decision support tool: flagging deviations, prioritizing the most critical cases, and relieving doctors of routine image review. This can free up time for clinical work where human expertise is most needed.

2. Drug development and clinical trials

Developing a new Pharma an average of 10–12 years and costs billions. AI can speed up several steps:

  • Identify molecules with high potential,
  • Predict toxicity and side effects,
  • Analyze clinical trial data in real time.

Example: During the COVID-19 pandemic, AI was used to analyze existing substances and identify candidates for re-evaluation. This type of reuse by Pharma save both time and resources.

3. Patient-centered care and logistics

AI is playing an increasingly important role in patient-centered care and healthcare logistics, not least by contributing to more proactive and person-centered working methods. The technology is used, among other things, to predict the risk of readmission, transcribe medical records, optimize scheduling and resource allocation, and analyze data from wearable technology. The latter can, for example, help identify early signs of deterioration in chronically ill patients, thereby enabling faster intervention and better continuity of care.

But why is it taking so long?

AI in healthcare shows great promise, and the results from pilot projects demonstrate that the technology works. Nevertheless, we are seeing few widespread implementations. It is not the technology that is the obstacle, but everything that surrounds it. Data quality is the first problem. Patient data is often fragmented, incomplete, or inconsistent, and AI is only as good as the data it is trained on. Without a robust information structure, we risk building smart systems on uncertain foundations.

Regelverken är en annan utmaning. Inom life science ställs höga krav på spårbarhet, validering och dataintegritet. När AI-modeller är adaptiva och föränderliga blir dessa krav svåra att översätta. Hur validerar man något som lär sig över tid?

Trust is also crucial. Neither doctors nor patients accept decisions that cannot be explained. AI that functions as a "black box" has no place in the clinic; we need systems that are comprehensible, transparent, and accountable.

And then there is the culture. Healthcare moves slowly, and rightly so. New technologies require evidence, training, and acceptance. But this also means that we risk falling behind, not because the technology does not exist, but because we have not changed enough around it. So it is not a question of what AI can do, but whether we are prepared to adapt our infrastructure, our regulations, and our thinking in order to actually put the technology to use. For real. In everyday life. Where it can make a real difference.

Hype vs. reality

AI is often touted as a solution to the most pressing challenges in healthcare, sometimes almost as a miracle cure. But to understand the true potential of the technology, we must distinguish between what works in controlled research environments and what can actually be implemented in everyday clinical practice.

Take diagnostics as an example. The claim that AI can replace doctors sounds dramatic, but misses the point: AI can certainly provide strong decision support, but human judgment is still crucial. Holistic assessments, ethical considerations, and patient communication are not something we can easily automate.

The same applies to drug development. AI can certainly shorten certain stages, such as identifying potential molecules or analyzing large amounts of data. But the entire development chain, from preclinical research to approval, still depends on rigorous testing and long-term validation. And when it comes to AI as the solution to the shortage of resources in healthcare, we need to think twice. The technology can improve efficiency, but only if it is implemented with the right infrastructure, access to relevant data, and strong change management. Without this, we risk creating more bottlenecks than we solve.

AI is a powerful tool. But in healthcare, it needs to be used with an understanding of the system, a long-term perspective, and respect for the clinical context. Then it can make a real difference, not as a replacement, but as an enabler.

Report: Study on the deployment of AI in healthcare

A new report from the European Commission, produced by PwC and Open Evidence, provides a broad and nuanced picture of how artificial intelligence is taking Location healthcare and why development is still characterized by more potential than impact. Despite extensive technological advances and a growing range of available AI solutions, their introduction into clinical practice remains limited. The report highlights both the structural barriers that are slowing down development and the conditions that need to be in Location AI to contribute to more accessible, equitable, and sustainable healthcare.

AI has already proven its ability to relieve the burden on healthcare systems in many parts of the world. From shortening lead times in diagnostics to freeing up time from administration, improving resource utilization, and facilitating triage. Examples from hospitals in the US, Norway, Israel, and Spain, among others, show how the right AI tools in the right context can bring about concrete improvements in workflows, decision-making, and the working environment.

However, the report also shows why progress is slow. Among the bottlenecks are:

  • Lack of interoperability and common data standards
  • Technical vulnerability and difficulties in validating AI systems in different contexts
  • Fragmented legislation – despite new initiatives such as the AI Act and EHDS
  • Organizational barriers, such as low digital maturity or unclear ownership
  • Skepticism and low trust, both from patients and the profession

At the same time, the report points out that the EU, as a whole, has a responsibility and an opportunity to take the lead in scaling up AI in a safe, ethical, and value-creating way. However, this requires a systemic perspective, and that the issue of technology is always linked to issues of working environment, competence, trust, and process.

What does it take to take AI from pilot to everyday use?

For AI to become an established part of healthcare practices and not just isolated initiatives, a comprehensive approach is required:

1. Data infrastructure

  • This is where the EHDS regulation comes in, which could solve these problems. Sweden has a relatively well-developed infrastructure compared to other countries.
  • Build national and regional platforms for the secure sharing of health data.
  • Standardize formats and metadata to enable interoperability.

2. Regulatory frameworks adapted for AI

  • The EU's AI Act and the FDA's CSA initiative (Food and Drug Administration's initiative: "Computer Software Assurance for Production and Quality System Software") are steps in the right direction, but need to be translated into practical methods for validation and operation.
  • Requirements for "explainable AI" will be crucial for building trust.

3. Interdisciplinary teams

  • AI projects must be driven by collaboration between data analysis experts, clinicians, regulatory experts, and patients.
  • Without clinical validation, the technology risks becoming unusable in everyday life.

4. Trust and ethics

  • Transparency regarding how data is used and how models are trained.
  • Ethical guidelines to avoid bias and discrimination.
  • Patient communication: AI must not be perceived as "a decision made by a machine."

Conclusion

AI can improve diagnostics, drug development, and healthcare logistics. But the big challenge lies not in the algorithms, but in the data, regulations, culture, and trust. For AI to truly deliver value in healthcare, we need to move beyond the hype and build a robust infrastructure for implementation. It is about not seeing AI as a replacement for humans, but as a tool that enhances human competence.

As long as we understand the limitations and work systematically with quality, ethics, and compliance, AI can become one of the most important catalysts for more equal, safe, and effective healthcare. The real question is therefore no longer whether AI will enter healthcare, but how quickly we are prepared to really let it in and what challenges we want to solve with it.

In this article

Related content

AI in Life Sciences
AI‑skribenter i vården: mellan hypen och verkligheten
AI in Life Sciences
Framtidens compliance formas nu
Read more
AI in Life Sciences
#73 AI tar plats inom compliance och lyfter expertrollen till nya höjder
Read more
AI in Life Sciences
AI‑skribenter i vården: mellan hypen och verkligheten
Read more
AI in Life Sciences
Framtidens compliance formas nu
Read more
AI in Life Sciences
#73 AI tar plats inom compliance och lyfter expertrollen till nya höjder
Read more
Stay up to date

SUBSCRIBE to our newsletter